Akanda (AKAN) Total Non-Current Liabilities (2020 - 2025)
Akanda (AKAN) posted quarterly Total Non-Current Liabilities of $12.0 million for Q4 2025, up 229.53% year-over-year from $3.6 million in Q4 2024, and up 16813.78% quarter-over-quarter from $70869.0 in Q2 2025.
Akanda (AKAN) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Akanda's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $12.0 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 229.53% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $12.0 million (up 229.53% YoY), while the FY2025 annual figure was $12.0 million, up 229.53% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $12.0 million, up from $70869.0 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $12.0 million in Q4 2025, with the low at $70869.0 in Q2 2025.
- The 5-year median for Total Non-Current Liabilities is $2.5 million (2022), against an average of $3.5 million.
- The sharpest annual moves came in 2021 and 2025: Total Non-Current Liabilities slumped 69.9% in 2021, then surged 229.53% in 2025.
- Akanda's Total Non-Current Liabilities stood at $2.0 million in 2021, then surged by 38.9% to $2.7 million in 2022, then declined by 9.16% to $2.5 million in 2023, then surged by 45.67% to $3.6 million in 2024, then soared by 229.53% to $12.0 million in 2025.
- Business Quant data shows AKAN's Total Non-Current Liabilities at $12.0 million in Q4 2025, $70869.0 in Q2 2025, and $3.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 334.00 Mn |
| 10 | Akanda | 266,801.66 | 266,801.66 | - | 11.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.99 Mn |
| Jun 30, 2025 | 70,869.00 |
| Dec 31, 2024 | 3.64 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Jun 30, 2022 | 2.57 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 6.58 Mn |